Augmented Reality And Virtual Reality In Healthcare Market Size, Share & Trends Analysis Report By Component (Hardware, Software), By Technology Type (Augmented Reality, Virtual Reality), By Region, And Segment Forecasts, 2024 - 2030

Augmented Reality And Virtual Reality In Healthcare Market Size, Share & Trends Analysis Report By Component (Hardware, Software), By Technology Type (Augmented Reality, Virtual Reality), By Region, And Segment Forecasts, 2024 - 2030


Augmented Reality And Virtual Reality in Healthcare Market Growth & Trends

The global augmented reality and virtual reality in healthcare market size are expected to reach USD 11.3 billion by 2030, at a projected CAGR of 16.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing advancements and digital disruptions in the healthcare system, rising healthcare expenditures and the rising need for efficient and innovative solutions to enhance clinical and operational outcomes are contributing to the market's growth. Augmented reality (AR) and virtual reality (VR) are widely adopted in surgical departments, education and training, simulation labs, and chronic pain management.

In February 2024, Dr. Benjamin Warf, a neurosurgeon affiliated with Boston Children's Hospital, in the MIT nano Immersion Lab, operated his avatar from a significant distance in real-time, and medical residents from Brazil observed, interacted, and learned in a 3D environment. The AR VR-powered lab facilitated the resident's practice on intricate surgical procedures using a simulated infant brain model more than 3,000 miles from the physical location.

During the COVID-19 pandemic, AR and VR experienced increased demand, as they played an important role in avoiding travel and social contacts while providing effective audiovisual communication and virtual presence. Furthermore, the integration of AR and VR in healthcare extended beyond training and education to directly impact the treatment and rehabilitation of COVID-19 patients. Also, the virtual rehabilitation programs, designed to address the physical and mental health challenges faced by infected individuals, proved effective in managing pain and facilitating recovery, thereby driving the market growth.

AR technological solutions are widely used in surgical procedures, fitness management, education and training, patient care management, and medical imaging. Recent advancements in AR components have reduced the cost of augmented reality solutions and enhanced customer experience. The increasing prevalence of diseases and surgeries, along with advancements in healthcare infrastructure and IT, are some driving forces. For instance, in April 2024, KIMS Hospital in India used AR and AI in neurosurgery to reduce complexities and human errors.

Moreover, due to the introduction of several solutions, supportive government policies, technical advancements, and the presence of key companies, the market is expected to grow significantly during the forecast period. For instance, in September 2023, the Des Moines Fire Department (DMFD) and the Simulation in Motion-Iowa (SIM-IA), a simulation clinical learning program by the University of Iowa, launched an augmented reality & virtual reality in healthcare training truck. This simulation truck featured an ambulance box, video recording for analysis & debriefing, four human patient simulators, and a simulated emergency bay to provide high-quality, evidence-based clinical education to hospital professionals & EMS across the state.

Augmented Reality And Virtual Reality In Healthcare Market Report Highlights
  • Based on component, the hardware segment dominated the market in 2023. Due to their audio-visual significance, AR and VR are being widely adopted in education, simulation, telemedicine, and data visualization. Increasing product development in this space is contributing to market growth.
  • Based on technology type, the AR segment dominated the market in 2023. Factors such as technological advancements, growing demand for efficient treatment, increasing public & private investments, rising number of mergers and acquisitions, and reducing prices of head-mounted devices are among a few factors that are driving the demand for AR.
  • North America dominated the global market in 2023 with a revenue share of 39.1%. The market growth can be attributed to the increasing adoption of AR and VR technologies, growing R&D initiatives, and favorable government initiatives.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. Technology type
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component outlook
2.2.2. Technology type outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Augmented Reality & Virtual Reality in Healthcare Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Augmented Reality & Virtual Reality in Healthcare Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Impact of COVID-19
Chapter 4. Augmented Reality & Virtual Reality in Healthcare Market: Component Estimates & Trend Analysis
4.1. Component Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Augmented Reality & Virtual Reality in Healthcare Market by Component Outlook
4.4. Hardware
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Software
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Service
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Augmented Reality & Virtual Reality in Healthcare Market: Technology Type Estimates & Trend Analysis
5.1. Technology Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Augmented Reality & Virtual Reality in Healthcare Market by Technology Type Outlook
5.4. Augmented Reality
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Surgical Applications
5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Rehabilitation
5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.4. Training and Continuing Medical Education
5.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Virtual Reality
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Simulation
5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Diagnostics
5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Virtual Reality Exposure Therapy (VRET)
5.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Rehabilitation
5.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.6. Pain Distraction
5.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Augmented Reality & Virtual Reality in Healthcare Market: Regional Estimates & Trend Analysis, By Component, By Technology Type
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Singapore
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Innovators
7.4. Vendor Landscape
7.4.1. List of key distributors and channel partners
7.4.2. Key customers
7.4.3. Key company market share analysis, 2023
7.4.4. CAE Healthcare Inc.
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Siemens Healthineers
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Koninklijke Philips N.V.
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Hologic, Inc.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. EON Reality, Inc.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Intuitive Surgical Operations, Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. GE HealthCare
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Layar.eu
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. WorldViz, Inc.
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. TheraSim, Inc.
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings